CAS: 193969-08-3

10-o-Vanilloylaucubin is a naturally occurring iridoid glycoside, which is a type of secondary metabolite primarily found in certain plant species. It is typically sourced from various members of the plant families Gentianaceae and Plantaginaceae. The compound exhibits a unique mode of action that involves modulating biological pathways associated with inflammation and cell proliferation. Its potential to interfere with these pathways positions it as a candidate for further research into anti-inflammatory and anti-cancer therapies. Recent studies have focused on the biochemical interactions of 10-o-Vanilloylaucubin at the molecular level, showing promising results in modulating immune responses and exhibiting cytotoxic effects on certain cancer cell lines. These findings suggest that 10-o-Vanilloylaucubin could be developed as a novel therapeutic agent. Its integration into drug discovery processes could help illuminate new pathways for treating chronic inflammatory conditions and various forms of cancer, underscoring the importance of continuing phytochemical research in this area. As such, it holds significant potential in the ongoing efforts to explore and harness plant-based compounds for medicinal use.

10-O-Vanilloylaucubin shows significant writhing inhibition following oral administration at doses of 25 mg/kg.suggests that it has analgesic effects.